Florida To Receive More Than $870 Million For Opioid Abatement From Settlements With CVS, Teva, Allergan, And Endo
January 26, 2023
CVS, Teva, Allergan, and Endo have settled with Florida for 870 Million: The Florida Attorney General announced on March 30, 2022 the securement of more than $870 million for opioid abatement from CVS Health Corporation, CVS Pharmacy, Inc., Teva Pharmaceuticals Industries Ltd., and Allergan PLC. CVS[...]
Continue Reading
1 In 4 Patients Admitted To U.S. Hospitals Are Harmed
January 22, 2023
1 In 4 Patients Admitted To U.S. Hospitals Are Harmed: The results of a study entitled “The Safety of Inpatient Health Care” published on January 12, 2023 in The New England Journal of Medicine concluded: “Adverse events were identified in nearly one in four admissions, and approxi[...]
Continue Reading
How Often Do Filshie Clips Migrate?
January 19, 2023
How Often Do Filshie Clips Migrate? — In applying for premarket approval of the Filshie Clip System in 1993, the applicant reported clip migration or expulsion as an adverse event at the rate of 0.13%. (See pages 11 and 49 of 85). “Of the 5454 women who were enrolled in the ten prospecti[...]
Continue Reading
Filshie Clip Litigation Early-Stage Victory!
January 18, 2023
Filshie Clip Litigation Early-Stage Victory! — In its Order filed on January 17, 2023, the United States District Court for the Northern District of Georgia DENIED the Filshie clip Defendants’ Motions to Dismiss. Background Plaintiffs are three women and one of their spouses who allege t[...]
Continue Reading
Florida Settles Opioid-Related Claims With Walmart
January 16, 2023
Florida Settles Opioid-Related Claims With Walmart: On October 20, 2022, Florida’s Attorney General announced a statewide agreement with Walmart to dispense naloxone to first responders across Florida. Walmart agreed to dispense 672,000 naloxone kits the state procured as part of an earlier ag[...]
Continue Reading